• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Chiesi USA

Anonymous board for Chiesi USA
Replies
3
Views
1K
anonymous
Replies
6
Views
5K
anonymous
ion
Replies
0
Views
1K
anonymous
Replies
1
Views
2K
anonymous
Replies
79
Views
19K
anonymous
Replies
7
Views
2K
anonymous
Replies
0
Views
1K
anonymous
Replies
26
Views
13K
anonymous
Replies
3
Views
3K
anonymous
Replies
0
Views
3K
anonymous
Replies
3
Views
5K
anonymous
Replies
14
Views
4K
anonymous
Replies
16
Views
11K
anonymous
Replies
7
Views
3K
anonymous
Replies
6
Views
3K
anonymous
Replies
44
Views
26K
anonymous
Replies
10
Views
12K
anonymous
Replies
2
Views
3K
anonymous